ranbaxy pharmaceuticals

The U.S. Food and Drug Administration on Tuesday put the Indian generic drug giant Ranbaxy on notice that it would block entry to the U.S. market of 25 generic prescription drugs widely used by American consumers. The FDA "warning letter" faulted Ranbaxy, the world's largest manufacturer of generic pharmaceuticals, for observing inadequate quality controls and manufacturing standards in the production of generic versions of drugs used to treat diabetes, high cholesterol, epilepsy and infections, among other conditions.

http://latimesblogs.latimes.com/booster_shots/2008/09/fda-issues-warn.html